Financials
- Market Capitalization 26.39 M
- Employee 19
- Founded 2015
- CEO N/A
- Website www.abvcpharma.com
- Headquarter Nevada, United States
- FIGI BBG000Q844Z2
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-5.46
ratio cours/chiffre d'affaires
—
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4396 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.63 USD | -12.37% | -7.91% | -1.21% | -82.86% | 27.60 M USD | ||
| 4405 | MCRB Seres Therapeutics, Inc. - Common Stock | 2.68 USD | -1.11% | -6.94% | -46.40% | -67.44% | 26.64 M USD | ||
| 4415 | BYSI BeyondSpring, Inc. - Ordinary Shares | 0.62 USD | +1.64% | -18.42% | -18.42% | -63.53% | 25.49 M USD | ||
| 4419 | EVAX Evaxion A/S - American Depositary Share | 3.00 USD | -2.28% | -7.41% | -5.36% | -9.64% | 25.02 M USD |